Davitte Cogen
WinnMed(US)Cancer Clinic(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Chronic Lymphocytic Leukemia Research, SARS-CoV-2 and COVID-19 Research, Ubiquitin and proteasome pathways, T-cell and B-cell Immunology
Most-Cited Works
- → Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells(2016)60 cited
- → Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination(2022)23 cited
- → T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia(2024)7 cited
- → Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti–Tumor Necrosis Factor Therapy(2024)4 cited
- → Aurora Kinase Is a Therapeutic Target in Ibrutinib-Resistant Waldenstrom Macroglobulinemia: In-Silico Target Identification and in-Vitro Validation(2015)3 cited
- → Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma(2015)2 cited
- → VLX1570, a First in Class Dub Inhibitor, Modulates BCR Signaling and CXCR4 Expression and Demonstrates Significant In Vivo Antitumor Activity in a Murine Model of Human Waldenstrom Macroglobulinemia(2015)2 cited
- → A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer(2025)1 cited
- → Cell-Mediated Immune Response after COVID 19 Vaccination in Patients with Inflammatory Bowel Disease(2022)1 cited
- → T-Cells Immune Cluster Analysis Using Cytof Identifies Unique Patient Subgroups with TP53 Mutation and Predicts Complete Remission (CR) in Patients with Acute Myeloid Leukemia (AML) Receiving Venetoclax Plus Hypomethylating Agent Therapy(2023)